Phase 2 N=1,586 Automated Real-time Feedback on CPR Study
Heart Arrest
Primary: Rate of ROSC During the Prehospital Resuscitation — 361; 345 Participants — p=0.96
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=283 A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)
Arthritis, Rheumatoid
Primary: Percentage of Patients With ACR20 (American College of Rheumatology) Response at Week 24, Based on Erythrocyte Sedimentation Rate (ESR) — 15.9; 34.7; 25.4; 28.2…
Phase 2 N=115 Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
Pterygium
Primary: Number of Pterygium Hyperemia Responders at Week 16 — 6; 8 Participants
Phase 2 N=10 Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
Lipoma
Primary: The Average Percent Volume Reduction in the Lipoma. — 50 Percent Volume reduction (cc^3)
Phase 2 N=9 Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
Kidney Transplantation · Kidney Disease · Kidney Failure
Primary: Overall Participant Survival at One Year Post Kidney Transplant — 4; 5 participants
Phase 2 N=109 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Infection, Human Immunodeficiency Virus I
Primary: Plasma Amprenavir (APV) AUC (0-tau[τ]) — 22.3; NA; 24.1; NA hr*µg/mL
Phase 2 N=51 The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
Treatment · Placebo
Primary: California Verbal Learning Test-II (CLVT-II) — 55.84; 55.39 age adjusted t-scores
Phase 2 N=32 Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer
Small Cell Lung Cancer
Primary: Phase I Toxicity Based Upon Adverse Events Clasified by the NCI Common Terminology Ctireria Version 2.0 (Phase I) — 3; 1; 1; 1 participants
Phase 2 N=37 Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis
Aphthous Stomatitis
Primary: Effect of Ibuprofen, Diphenhydramine and Aluminium MgS Measured on Decrease in Pain Level and Burning Sensation — 3.176; 3.821 scores in Visual Analogue Scale
Phase 2 N=62 Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)
Breast Cancer
Primary: The Number of Participants That Have Sentinel Nodes Which Are Radioactive or Blue, or Radioactive and Blue or Have Efferent Blue Lymphatics Leading up to the Sentinel…
Phase 2 N=36 Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
Pulmonary Hypertension
Primary: The Incidence of Confirmed Serum Alanine Aminotransferase (ALT) or Aspartate Aminotransferase (AST) Concentrations > 3 x the Upper Limit of Normal (ULN) Considered to be…
Phase 2 N=35 Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients
Breast Cancer
Primary: Severity of Dermatitis in Radiation Treatment Site in Breast Cancer Patients — 2.6; 3.4 units on a scale — p=0.0077
Phase 2 N=139 Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination
Meningitis · Meningococcal Meningitis · Meningococcal Infections
Primary: Number of Participants Reporting Solicited Injection Site or Systemic Reactions Following Vaccination With Either Menomune or Menactra Vaccine — 8; 33; 0; 1 Participants
Phase 2 N=46 Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
Lung Cancer
Primary: Median Time to Disease Progression — 152 Days
Phase 2 N=13 Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)
Late Infantile Metachromatic Leukodystrophy
Primary: Relative Changes (%) in Gross Motor Function Measurement (GMFM) — -2.98; -5.42; -5.28 Relative % change in total GMFM-88 SOT — p=0.4013